Cargando…
Metaplastic Carcinoma of the Breast: Case Series of a Single Institute and Review of the Literature
Metaplastic carcinoma of the breast (MpBC) is a very rare and aggressive type of breast cancer. Data focusing on MpBC are limited. The aim of this study was to describe the clinicopathological features of MpBC and evaluate the prognosis of patients with MpBC. Eligible articles about MpBC were identi...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204473/ https://www.ncbi.nlm.nih.gov/pubmed/37218987 http://dx.doi.org/10.3390/medsci11020035 |
_version_ | 1785045842245189632 |
---|---|
author | Papatheodoridi, Alkistis Papamattheou, Eleni Marinopoulos, Spyridon Ntanasis-Stathopoulos, Ioannis Dimitrakakis, Constantine Giannos, Aris Kaparelou, Maria Liontos, Michalis Dimopoulos, Meletios-Athanasios Zagouri, Flora |
author_facet | Papatheodoridi, Alkistis Papamattheou, Eleni Marinopoulos, Spyridon Ntanasis-Stathopoulos, Ioannis Dimitrakakis, Constantine Giannos, Aris Kaparelou, Maria Liontos, Michalis Dimopoulos, Meletios-Athanasios Zagouri, Flora |
author_sort | Papatheodoridi, Alkistis |
collection | PubMed |
description | Metaplastic carcinoma of the breast (MpBC) is a very rare and aggressive type of breast cancer. Data focusing on MpBC are limited. The aim of this study was to describe the clinicopathological features of MpBC and evaluate the prognosis of patients with MpBC. Eligible articles about MpBC were identified by searching CASES SERIES gov and the MEDLINE bibliographic database for the period of 1 January 2010 to 1 June 2021 with the keywords metaplastic breast cancer, mammary gland cancer, neoplasm, tumor, and metaplastic carcinoma. In this study, we also report 46 cases of MpBC stemming from our hospital. Survival rates, clinical behavior, and pathological characteristics were analyzed. Data from 205 patients were included for analysis. The mean age at diagnosis was 55 (14.7) years. The TNM stage at diagnosis was mostly stage II (58.5%) and most tumors were triple negative. The median overall survival was 66 (12–118) months, and the median disease-free survival was 56.8 (11–102) months. Multivariate Cox regression analysis revealed that surgical treatment was associated with decreased risk of death (hazard ratio 0.11, 95% confidence interval 0.02–0.54, p = 0.01) while advanced TNM stage was associated with increased risk of death (hazard ratio 1.5, 95% confidence interval 1.04–2.28, p = 0.03). Our results revealed that surgical treatment and TNM stage were the only independent risk factors related to patients’ overall survival. |
format | Online Article Text |
id | pubmed-10204473 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102044732023-05-24 Metaplastic Carcinoma of the Breast: Case Series of a Single Institute and Review of the Literature Papatheodoridi, Alkistis Papamattheou, Eleni Marinopoulos, Spyridon Ntanasis-Stathopoulos, Ioannis Dimitrakakis, Constantine Giannos, Aris Kaparelou, Maria Liontos, Michalis Dimopoulos, Meletios-Athanasios Zagouri, Flora Med Sci (Basel) Review Metaplastic carcinoma of the breast (MpBC) is a very rare and aggressive type of breast cancer. Data focusing on MpBC are limited. The aim of this study was to describe the clinicopathological features of MpBC and evaluate the prognosis of patients with MpBC. Eligible articles about MpBC were identified by searching CASES SERIES gov and the MEDLINE bibliographic database for the period of 1 January 2010 to 1 June 2021 with the keywords metaplastic breast cancer, mammary gland cancer, neoplasm, tumor, and metaplastic carcinoma. In this study, we also report 46 cases of MpBC stemming from our hospital. Survival rates, clinical behavior, and pathological characteristics were analyzed. Data from 205 patients were included for analysis. The mean age at diagnosis was 55 (14.7) years. The TNM stage at diagnosis was mostly stage II (58.5%) and most tumors were triple negative. The median overall survival was 66 (12–118) months, and the median disease-free survival was 56.8 (11–102) months. Multivariate Cox regression analysis revealed that surgical treatment was associated with decreased risk of death (hazard ratio 0.11, 95% confidence interval 0.02–0.54, p = 0.01) while advanced TNM stage was associated with increased risk of death (hazard ratio 1.5, 95% confidence interval 1.04–2.28, p = 0.03). Our results revealed that surgical treatment and TNM stage were the only independent risk factors related to patients’ overall survival. MDPI 2023-05-19 /pmc/articles/PMC10204473/ /pubmed/37218987 http://dx.doi.org/10.3390/medsci11020035 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Papatheodoridi, Alkistis Papamattheou, Eleni Marinopoulos, Spyridon Ntanasis-Stathopoulos, Ioannis Dimitrakakis, Constantine Giannos, Aris Kaparelou, Maria Liontos, Michalis Dimopoulos, Meletios-Athanasios Zagouri, Flora Metaplastic Carcinoma of the Breast: Case Series of a Single Institute and Review of the Literature |
title | Metaplastic Carcinoma of the Breast: Case Series of a Single Institute and Review of the Literature |
title_full | Metaplastic Carcinoma of the Breast: Case Series of a Single Institute and Review of the Literature |
title_fullStr | Metaplastic Carcinoma of the Breast: Case Series of a Single Institute and Review of the Literature |
title_full_unstemmed | Metaplastic Carcinoma of the Breast: Case Series of a Single Institute and Review of the Literature |
title_short | Metaplastic Carcinoma of the Breast: Case Series of a Single Institute and Review of the Literature |
title_sort | metaplastic carcinoma of the breast: case series of a single institute and review of the literature |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204473/ https://www.ncbi.nlm.nih.gov/pubmed/37218987 http://dx.doi.org/10.3390/medsci11020035 |
work_keys_str_mv | AT papatheodoridialkistis metaplasticcarcinomaofthebreastcaseseriesofasingleinstituteandreviewoftheliterature AT papamattheoueleni metaplasticcarcinomaofthebreastcaseseriesofasingleinstituteandreviewoftheliterature AT marinopoulosspyridon metaplasticcarcinomaofthebreastcaseseriesofasingleinstituteandreviewoftheliterature AT ntanasisstathopoulosioannis metaplasticcarcinomaofthebreastcaseseriesofasingleinstituteandreviewoftheliterature AT dimitrakakisconstantine metaplasticcarcinomaofthebreastcaseseriesofasingleinstituteandreviewoftheliterature AT giannosaris metaplasticcarcinomaofthebreastcaseseriesofasingleinstituteandreviewoftheliterature AT kapareloumaria metaplasticcarcinomaofthebreastcaseseriesofasingleinstituteandreviewoftheliterature AT liontosmichalis metaplasticcarcinomaofthebreastcaseseriesofasingleinstituteandreviewoftheliterature AT dimopoulosmeletiosathanasios metaplasticcarcinomaofthebreastcaseseriesofasingleinstituteandreviewoftheliterature AT zagouriflora metaplasticcarcinomaofthebreastcaseseriesofasingleinstituteandreviewoftheliterature |